Sign in
4

Changes in Ownership

Kairos Pharma, LTD. Filed Acc 0001493152-24-047526

Chief Financial Officer bought 2,500 shares at $1.50 ($3,750)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Samuelson Doug Chief Financial Officer 2024-11-22 Purchase +2,500 $1.50 $3,750 60,796 D
Open-market purchases · 2,500 sh · avg $1.50 · $3,750
Loading xslF345X05/ownership.xml…